Top diabetes drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

Loading statistic...
Revenue in million U.S. dollars
Actos2,736.4
Januvia2,323.8
Lantus2,064.7
Lantus Solostar1,773.3
Novolog1,073.7
Humalog1,004.1
Levemir947.8
Novolog Flexpen897
Janumet841.2
Victoza 3-Pak587.9
© Statista 2017

Show further information

Show sources information

AdvertisementTableau Software
 
About This Statistic

This statistic represents the top diabetes drugs in the United States, based on revenue between July 2011 and June 2012. In this period, diabetes drug Actos generated around 2.7 billion U.S. dollars of revenues.

Special Functions
Download as ...
Graphic (PNG)
Excel (XLS)
PowerPoint (PPT)
PDF
Options
Settings
Print
Research Alerts
Download started
Please be patient - this may take a moment

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Top pharmaceutical drugs"

  • Global overview
  • Select therapy classes - global
The most important statistics
  • U.S. overview
The most important statistics
  • Select therapy classes - U.S.

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions